Abstract 5050: KCNJ2 constitutes a marker and therapeutic target of high-risk medulloblastomas von Valdora, Francesca, Freier, Florian, Garzia, Livia, Ramaswamy, Vijay, Seyler, Claudia, Hielscher, Thomas, Brady, Nathan, Northcott, Paul A., Kool, Marcel, Jones, David TW, Witt, Hendrik, Tonini, Gian Paolo, Scheurlen, Wolfram, Katus, Hugo A., Kulozik, Andreas E., Zitron, Edgar, Korshunov, Andrey, Lichter, Peter, Taylor, Michael D., Pfister, Stefan M., Remke, Marc

Volltext